New heart test could spare transplant patients from risky biopsies
NCT ID NCT06656065
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study is testing a new way to monitor heart transplant patients for rejection using a simple catheter-based measurement called IMR. The goal is to see if this test can identify high-risk patients and reduce the need for invasive biopsies. Researchers will follow 100 heart transplant recipients for one year.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this could lead to a safer, less invasive way to monitor heart transplant patients for rejection, potentially reducing the need for risky biopsies.
What could go wrong
This is an observational study, not a treatment trial. It may not change clinical practice if the IMR measurement does not reliably predict rejection or outcomes.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEART TRANSPLANT REJECTION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hospital Miguel Servet
RECRUITINGZaragoza, Zaragoza, 50009, Spain
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
-
Hospital Universitario de Bellvitge
ACTIVE_NOT_RECRUITINGL'Hospitalet de Llobregat, Barcelona, 08907, Spain